Rising Demand for Blood Products & High Prevalence of Blood Diseases Spur Demand for Apheresis Equipment, According to New Report by Global Industry Analysts, Inc.

• 

Apheresis Equipment: A Global Strategic Business Report

San Jose, California (PRWEB) August 27, 2013

Follow us on LinkedIn – Global market for Apheresis continues to witness steady growth driven by the rising adoption of therapeutic and donor apheresis. Key factors driving growth of donor apheresis include rising awareness over the safety of blood donation through apheresis, and growing number of platelet donations (Platelet Apheresis), plasma donations (Plasma Apheresis), leukocytes donation (Leukapheresis) and double red cell donation, among others. Donor apheresis procedures are growing in popularity driven by its advantages over whole blood collection.

Demand for therapeutic apheresis, on the other hand, is being driven by an increase in its prescribed use in the treatment of cancer and autoimmune disorders. Expanding application of therapeutic apheresis in treating circulatory disorders caused by excess blood proteins is also benefiting the market.

Promising areas of application for therapeutic apheresis include Waldenstrom's macroglobulinemia, Myasthenia gravis, Guillain-Barré syndrome, Hyperviscosity Syndromes, Paraproteinemia, Cryoglobulinemia, Goodpasture's syndrome, myeloproliferative disorders, among others. Increasing number of patients with autoimmune disorders and patients undergoing peripheral blood stem cell transplants are therefore driving adoption of therapeutic apheresis. Rise of apheresis as an anticancer therapy is also benefiting growth in the market. In the coming years, new avenues for therapeutic apheresis will emerge from the Pediatrics sector, given the huge unmet medical needs among infants and children.

Increased R&D investments in developing advanced apheresis equipment will also help spur growth by supporting adoption and acceptance of the procedure in the medical community. Favorable medical insurance and reimbursement policies are helping dissipate the unwillingness hitherto witnessed among vendors to invest in expensive apheresis equipment production. The need to maximize blood center efficiencies is also driving adoption of automated blood collection procedures like apheresis. Community blood centers are specially investing in apheresis equipment to meet the rising demand for safe blood among hospitals and patients.

Despite the numerous opportunities in store, the market will continue to face challenges in the form of high upfront equipment investments, bottlenecks in effectively building projects for the recruitment of voluntary non-remunerated plasma and platelet (apheresis) donors, high treatment costs, and lack of new clinical applications. Furthermore, issues related to histocompatibility of donors and shortage of highly skilled personnel will also restrain growth in the apheresis market.

As stated by the new market research report on Apheresis Equipment, the United States represents the largest market worldwide supported by high patient awareness, well-established healthcare infrastructure, government support, supportive reimbursement policies and availability of advanced blood collection technologies. Asia-Pacific is forecast to emerge as the fastest growing market with a projected CAGR of 12.6% over the analysis period. Growth in the region is led by rising incidence of disease and sickness, growing population, government focus on developing the healthcare infrastructure, steadily growing base of affluent middle class population and increasing healthcare spends. Increasing investments by leading companies in research and development, and rise in number of apheresis collection programs in some Asian countries for generating plasma for contract fractionation, also bodes well for the market.

Major players covered in the report include Asahi Kasei Medical Co. Ltd., B Braun Melsungen AG, Cerus Corporation, Fenwal Inc., Fresenius Medical Care North America (FMCNA), Haemonetics Corp., HemaCare Corp., Kaneka Corporation, Kawasumi Laboratories Inc., Medica SpA, NIKKISO Europe GmbH, Terumo BCT and Therakos, Inc. among others.

The research report titled “Apheresis Equipment: A Global Strategic Business Report”, announced by Global Industry Analysts, Inc., provides a comprehensive review of market trends, issues, drivers, company profiles, mergers, acquisitions and other strategic industry activities. The report provides market estimates and projections in US$ for all major geographic markets including the United States, Canada, Japan, Europe (France, Germany, Italy, UK, Spain, and Rest of Europe), Asia-Pacific (Australia, China, and Rest of Asia-Pacific), and Rest of World. Product segments analyzed in the report include Equipment for Donor Apheresis and Equipment for Therapeutic Apheresis. Also analyzed are apheresis equipment by procedure type including Erythrocytapheresis, Plasmapheresis, Plateletpheresis and Others.

For more details about this comprehensive market research report, please visit
http://www.strategyr.com/Apheresis_Equipment_Market_Report.asp.

About Global Industry Analysts, Inc.
Global Industry Analysts, Inc., (GIA) is a leading publisher of off-the-shelf market research. Founded in 1987, the company currently employs over 800 people worldwide. Annually, GIA publishes more than 1300 full-scale research reports and analyzes 40,000+ market and technology trends while monitoring more than 126,000 Companies worldwide. Serving over 9500 clients in 27 countries, GIA is recognized today, as one of the world's largest and reputed market research firms.

Follow us on LinkedIn.

Global Industry Analysts, Inc.
Telephone: 408-528-9966
Fax: 408-528-9977
Email: press(at)StrategyR(dot)com
Web Site: http://www.StrategyR.com/

###

PDF Print